Franz Baudenbacher

Franz Baudenbacher, associate professor of biomedical engineering and physics and deputy director of the Vanderbilt Institute for Integrative Biosystems Research and Education (VIIBRE), is one of four Vanderbilt entrepreneurs and innovators recognized by the university’s Center for Technology Transfer and Commercialization (CTTC) recognizes excellence in innovation through… Read More

InvisionHeart, LLC, a startup based on a wireless electrocardiogram (ECG) system developed at Vanderbilt, has been selected as one of 10 startups nationwide to participate in Google’s inaugural Demo Day April 2. CEO Josh Nickols will pitch the company to a roomful of investors at the spring Silicon Valley event. Read More

Nashville startup InvisionHeart is a finalist for the Global Food and Health Innovation Challenge and will compete next week for a $1 million prize. InvisionHeart was created by a group at Vanderbilt University, including biomedical engineering professor Franz Baudenbacher and cardiac anesthesiologist Susan Eagle. InvisionHeart was chosen from among 220… Read More

A strategy for commercializing a wireless electrocardiogram (ECG) has won top honors at this year’s TechVenture Challenge. Now in its third year, the Vanderbilt University initiative teaches students how to turn patented ideas developed by Vanderbilt faculty members into marketable products. The winning presentation pitched InvisionHeart, a smart health care… Read More

Vanderbilt investigators have discovered a new molecular mechanism associated with abnormal heart rhythms – arrhythmias – which account for about 10 percent of all deaths in the United States. Their findings, reported recently in The Journal of Clinical Investigation, could lead to novel arrhythmia treatments. The first author of… Read More